Coherus and Junshi Biosciences to Host Virtual Investor Event to Discuss Toripalimab and ASCO 2021 Highlights

NEXT STORY
Centessa Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
PREV STORY
Sorrento Announces Positive Results From Its License Partner, Kelun, on a Phase I Study of Safety and Pharmacokinetics of A166, a Novel HER2 ADC for Advanced HER2 Positive Breast Cancers
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

XBiotech Announces Granting of Canadian Patent for Treatment of Dermatological Pathologies

author_avatar
NASDAQ Market News

AzurRx Announces Addition of Dr. Vern Lee Schramm to the Board of Directors

NEW YORK, Oct. 16, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or ...

Steve Hamburg
Steve Hamburg

Burning Rock initiates the first prospective, multi-center pan-cancer early detection study in China

author_avatar
NASDAQ Market News